Viewing Study NCT01026233

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:41 AM
Ignite Modification Date: 2026-02-04 @ 3:02 PM
Study NCT ID: NCT01026233
Status: COMPLETED
Last Update Posted: 2014-12-12
First Post: 2009-12-02
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Cardiac Safety Study of Brentuximab Vedotin (SGN-35)
Sponsor: Seagen Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Disease, Hodgkin View
None Lymphoma, Large-Cell, Anaplastic View
None Lymphoma, Non-Hodgkin View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Antibodies, Monoclonal View
None Antibody-Drug Conjugate View
None Antigens, CD30 View
None Disease, Hodgkin View
None Drug Therapy View
None Hematologic Diseases View
None Immunotherapy View
None Lymphoma View
None monomethylauristatin E View
None Lymphoma, Large-Cell, Anaplastic View